APA (7th ed.) Citation

JL, V., P, I., R, S., C, B., P, B., N, B., . . . S, L. (2021). Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 p.L1950F Mutation: Case Report. Oncology research and treatment, 44(9), 495. https://doi.org/10.1159/000517616

Chicago Style (17th ed.) Citation

JL, Velthaus, Iglauer P, Simon R, Bokemeyer C, Bannas P, Beumer N, Imbusch CD, Goekkurt E, and Loges S. "Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 P.L1950F Mutation: Case Report." Oncology Research and Treatment 44, no. 9 (2021): 495. https://doi.org/10.1159/000517616.

MLA (9th ed.) Citation

JL, Velthaus, et al. "Lorlatinib Induces Durable Disease Stabilization in a Pancreatic Cancer Patient with a ROS1 P.L1950F Mutation: Case Report." Oncology Research and Treatment, vol. 44, no. 9, 2021, p. 495, https://doi.org/10.1159/000517616.